Announcements Trials
Browse Landscape

Phase

Phase 1 31Phase 1/2 18Phase 2 17Phase EARLY_PHASE1 4Phase NA 3Phase 4 2Phase 3 2Phase 2/3 1

Status

Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Recurrence 2Myelodysplastic Syndromes 2Leukemia, Lymphocytic, Chronic, B-Cell 2Neoplasms, Plasma Cell 1Neoplasm, Residual 1Myeloproliferative Disorders 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Leukemia, Lymphoid 1Leukemia 1Hematologic Neoplasms 1

Interventions

Brentuximab Vedotin 3relmacabtagene autoleucel 2fludarabine phosphate 2fludarabine 2Cytarabine 2Bortezomib 2Antilymphocyte Serum 2xihuang 1tocilizumab 1tislelizumab 1sofosbuvir-velpatasvir drug combination 1sintilimab 1rasburicase 1ledipasvir 1entecavir 1apatinib 1aflibercept 1acalabrutinib 1Urate Oxidase 1Trabectedin 1Thiotepa 1Thalidomide 1Tenofovir 1Tamsulosin 1Sofosbuvir 1Sevoflurane 1Rivaroxaban 1Ribavirin 1Radiotherapy 1Radiosurgery 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Recurrence × fludarabine × Clear all
NCT02784561 2016-05-27

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Chinese PLA General Hospital

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Recurrence

NCT02024308 2013-12-31

AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy

Changhai Hospital

Phase 4 Unknown
62 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡